Indian Pharma Market sees 13 percent growth in September sales: AIOCD-AWACS Report Medical Dialogues Team21 Oct 2021 5:51 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has witnessed a significant growth of 13% at Total Sales Audit (TSA) and 11% at Secondary Sales...
Abbott raises annual earnings outlook as COVID test sales rebound Ruchika Sharma21 Oct 2021 3:06 PM ISTNew Delhi: Abbott Laboratories said demand for its COVID-19 tests, especially rapid testing, rebounded as the U.S. wrestled with surging coronavirus...
No efficacy data of Regdanvimab on COVID variants in India: CDSCO panel rejects Abbott proposal Medical Dialogues Team10 Sept 2021 5:41 PM ISTNew Delhi: In a major setback to Abbott Healthcare, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has...
Abbott acquires medical device firm Walk Vascular Ruchika Sharma5 Sept 2021 9:00 AM ISTAbbott Park, III.: Abbott has recently announced that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a...
Abbott launches single-dose formulation of Carbetocin to prevent PPH in India Ruchika Sharma1 Sept 2021 2:07 PM ISTNew Delhi: Drug major Abbott on Tuesday said it has launched room-temperature-stable, single-dose formulation of carbetocin in India to help in the...
Abbott introduces Panbio COVID antigen self-test in India Ruchika Sharma13 July 2021 9:15 AM ISTIn India, Abbott will offer self-tests for use at home, assisted professional testing at point of care and laboratories, as well as workplace testing...
NPPA fixes ceiling price of Amphotericin B Emulsion Injection to treat Black Fungus Medical Dialogues Team11 July 2021 11:30 AM ISTNew Delhi: Through a recent Office Memorandum, the National Pharmaceutical Pricing Authority (NPPA) has confirmed the ceiling price of antifungal drug...
Abbott gets CDSCO panel nod for importing, marketing of Estradiol, Dydrogesterone FDC Medical Dialogues Team11 July 2021 10:30 AM ISTNew Delhi: Approving Phase III Clinical Trial (CT) waiver, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Abbott launches Amplatzer Piccolo Occluder in India to treat congenital heart defects in premature babies Ruchika Sharma16 Jun 2021 11:00 AM ISTThe Amplatzer Piccolo Occluder is a self-expanding, wire mesh device that is inserted through a small incision in the leg and guided through vessels...
NPPA fixes retail price of 12 formulations, Details Medical Dialogues Team6 Jun 2021 11:30 AM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Abbott collaborates with Nutrition Society of India to create awareness on clinical dietary recommendations for GI patients Ruchika Sharma13 March 2021 9:30 AM ISTKolkata: Metabolic syndrome and associated gastrointestinal (GI) conditions are becoming increasingly prevalent in the country with 33.5% of...
Include more govt sites for Phase III clinical trial of Ursodeoxycholic Acid Tablets: CDSCO panel to Abbott MD Bureau28 Feb 2021 11:15 AM ISTNew Delhi: Suggesting to include more government sites in Phase III Clinical trial protocol, the Central Drugs Standard Control Organization (CDSCO)...
